Reference Range Study for the Quantra System With the QPlus Cartridge in Pediatric Patients
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- HemoSonics LLC
- Study ID
- NCT07447713
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Coagulation
- Pediatric
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- Quantra System — DIAGNOSTIC_TESTDiagnostic device to monitor coagulation properties of a whole blood sample at the point-of-care.
Study Details
This study will determine reference range intervals for the parameters reported by the Quantra System with the QPlus Cartridge in pediatric patients.
Key Dates
- Start date
- Apr 15, 2026
- Status verified
- Feb 2026
- Primary completion
- Apr 30, 2027
- Completion
- May 30, 2027
Study Design
- Enrollment
- 240 participants (estimated)
Arms
- Arm: Pediatric patients
Primary Outcome Measure
Reference range intervals for measurement of Clot Time (CT) parameter [ Time Frame: Baseline, determined from a single blood draw ]
Central Contacts
- Deborah Winegar, PhD19192446990
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UCLA Mattel Children's Hospital | Los Angeles | California | 90095 | Department of Anesthesiology |
| Children's Healthcare of Atlanta | Atlanta | Georgia | 30329 | Department of Anesthesiology |
| Boston Children's Hospital | Boston | Massachusetts | 02115 | Department of Anesthesiology |
Find similar trials in Los Angeles, CA
Related Studies
- Evaluation of Pro-Inflammatory Leukocyte Activity in Patients Undergoing Cardiac SurgeryRecruiting · Boston Children's Hospital · Boston, Massachusetts
- A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).PHASE2/PHASE3 · Recruiting · Cytokinetics · Phoenix, Arizona
- Comparing a Team-Based Approach to Standard Well-Child Visits To Improve Preventive Care ServicesRecruiting · Seattle Children's Hospital · Honolulu, Hawaii
- Clinical Performance Evaluation of Native Whole Blood Samples of Patients on DOACs With the Perosphere ClotChek™Recruiting · Perosphere Technologies Inc. · Danbury, Connecticut